To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene VTI1BandCOX7A2P1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
286 supporting clones for gene VTI1BandCOX7A2P1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC001598 Lymph, Burkitt lymphoma VTI1BandCOX7A2P1.a 1 to 1198 1 to 1198 exact tiling clone, AAA   1198/2361
(50 %)
1 diff
(100.0 %id)
BE397713 Burkitt lymphoma, lymph VTI1BandCOX7A2P1.a 5 to 688 33 to 713       681/733
(92 %)
12 diff
(98.4 %id)
BE267556 Burkitt lymphoma, lymph VTI1BandCOX7A2P1.a 20 to 688 1 to 665       665/672
(98 %)
8 diff
(98.9 %id)
BE270053 Burkitt lymphoma, lymph VTI1BandCOX7A2P1.a 20 to 542 1 to 523       523/523
(100 %)
0 diff
(100 %id)
BE513333 Burkitt lymphoma, lymph VTI1BandCOX7A2P1.a 20 to 618 1 to 599       599/599
(100 %)
0 diff
(100 %id)
CN421432 embryonic stem cells, cell lines H1, H7, andH9 VTI1BandCOX7A2P1.a 209 to 955 1 to 748       748/748
(100 %)
2 diff
(99.8 %id)
CN421433 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells VTI1BandCOX7A2P1.a 277 to 733 1 to 457       457/457
(100 %)
0 diff
(100 %id)
AA056932 uterus VTI1BandCOX7A2P1.a 372 to 644 1 to 274       274/284
(96 %)
6 diff
(97.9 %id)
BC042390 Cervix, carcinoma VTI1BandCOX7A2P1.a 507 to 5268 1 to 4762   tiling clone, available from MGC, AAA   4762/4762
(100 %)
0 diff
(100 %id)
AA045537 uterus VTI1BandCOX7A2P1.a 804 to 1201 419 to 21   AAA   399/403
(99 %)
1 diff
(99.8 %id)
BX369657   VTI1BandCOX7A2P1.a 916 to 1828 1 to 912       912/915
(99 %)
12 diff
(98.7 %id)
BX384061   VTI1BandCOX7A2P1.a 925 to 1853 932 to 1       932/932
(100 %)
11 diff
(98.9 %id)
BI253881 cervical carcinoma cell line, cervix VTI1BandCOX7A2P1.a 1141 to 1891 1 to 754       754/763
(98 %)
21 diff
(97.3 %id)
BE883034 leiomyosarcoma, uterus VTI1BandCOX7A2P1.a 1205 to 1853 28 to 681       654/950
(68 %)
6 diff
(99.4 %id)
BQ015934 lung, Metastatic Chondrosarcoma VTI1BandCOX7A2P1.a 1206 to 1881 694 to 19   AAA   676/676
(100 %)
2 diff
(99.8 %id)
DA245110 brain VTI1BandCOX7A2P1.a 1237 to 1829 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
AI719735 aorta VTI1BandCOX7A2P1.a 1329 to 1874 546 to 1       546/546
(100 %)
0 diff
(100 %id)
DA391691 thalamus VTI1BandCOX7A2P1.a 1434 to 2018 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
AI358215 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus VTI1BandCOX7A2P1.a 1466 to 1881 416 to 1       416/416
(100 %)
0 diff
(100 %id)
BE886923 leiomyosarcoma, uterus VTI1BandCOX7A2P1.a 1498 to 2201 1 to 704       704/857
(82 %)
7 diff
(99.2 %id)
AA365565 pineal body VTI1BandCOX7A2P1.a 1535 to 1840 1 to 306       306/306
(100 %)
0 diff
(100 %id)
AW959721   VTI1BandCOX7A2P1.a 1536 to 1881 1 to 346   AAA   346/346
(100 %)
0 diff
(100 %id)
DA401750 thalamus VTI1BandCOX7A2P1.a 1576 to 2105 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
BG621538 placenta VTI1BandCOX7A2P1.a 1662 to 2389 1 to 736       736/872
(84 %)
21 diff
(97.6 %id)
CN282819 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells VTI1BandCOX7A2P1.a 1735 to 2366 13 to 644       632/644
(98 %)
6 diff
(99.1 %id)
DA951693 Spleen VTI1BandCOX7A2P1.a 1742 to 2297 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB283710 uterus VTI1BandCOX7A2P1.a 1783 to 2324 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
CD172445 White Matter VTI1BandCOX7A2P1.a 1828 to 2686 1 to 862       862/867
(99 %)
11 diff
(98.8 %id)
BF794367 lymph, lymphoma, cell line VTI1BandCOX7A2P1.a 1874 to 2650 1 to 772       772/886
(87 %)
22 diff
(97.6 %id)
DA805070 brain VTI1BandCOX7A2P1.a 1881 to 2439 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA386887 thalamus VTI1BandCOX7A2P1.a 1955 to 2471 2 to 518   capped   517/517
(100 %)
0 diff
(100 %id)
BU662236 blood VTI1BandCOX7A2P1.a 2037 to 2745 724 to 16     Submitted on the opposite strand 709/724
(97 %)
6 diff
(99.2 %id)
BF528426 anaplastic oligodendroglioma with 1p/19qloss, brain VTI1BandCOX7A2P1.a 2138 to 2945 1 to 788       788/931
(84 %)
32 diff
(96.6 %id)
DB207175 trachea VTI1BandCOX7A2P1.a 2290 to 2920 2 to 632   capped   631/631
(100 %)
0 diff
(100 %id)
BF829927 head_normal VTI1BandCOX7A2P1.a 2366 to 2590 224 to 3     Submitted on the opposite strand 222/227
(97 %)
0 diff
(100 %id)
BQ720637 sympathetic trunk VTI1BandCOX7A2P1.a 2478 to 3404 1 to 917       917/917
(100 %)
27 diff
(97.1 %id)
BM552214 leiomyosarcoma, uterus VTI1BandCOX7A2P1.a 2491 to 3290 1 to 814       814/1100
(74 %)
20 diff
(98.2 %id)
DR159500 human embryonic stem cells differentiated toan early endodermal cell type VTI1BandCOX7A2P1.a 2545 to 3335 13 to 803       791/803
(98 %)
6 diff
(99.3 %id)
DA277979 corpus callosum VTI1BandCOX7A2P1.a 2598 to 3148 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BU509212 leiomyosarcoma, uterus VTI1BandCOX7A2P1.a 2682 to 3546 1 to 868       868/869
(99 %)
6 diff
(99.4 %id)
DA515183 brain VTI1BandCOX7A2P1.a 2751 to 3293 2 to 545   capped   544/544
(100 %)
3 diff
(99.5 %id)
F11995 brain, total brain VTI1BandCOX7A2P1.a 2754 to 3100 1 to 347       347/347
(100 %)
0 diff
(100 %id)
BQ435243 melanotic melanoma, skin VTI1BandCOX7A2P1.a 2756 to 3563 24 to 837       814/844
(96 %)
8 diff
(99.1 %id)
DA576593   VTI1BandCOX7A2P1.a 2790 to 3355 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BE785005 large cell carcinoma, lung VTI1BandCOX7A2P1.a 2872 to 3609 1 to 726       726/913
(79 %)
23 diff
(97.5 %id)
DA157123 amygdala VTI1BandCOX7A2P1.a 2889 to 3458 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA023140   VTI1BandCOX7A2P1.a 2971 to 3540 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
CN263781 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells VTI1BandCOX7A2P1.a 2980 to 3636 1 to 657       657/657
(100 %)
2 diff
(99.7 %id)
DA598460   VTI1BandCOX7A2P1.a 3048 to 3595 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
CB118837 Liver VTI1BandCOX7A2P1.a 3092 to 3672 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BY996732   VTI1BandCOX7A2P1.a 3224 to 3925 19 to 721       703/721
(97 %)
6 diff
(99.2 %id)
DA998996 breast, tumor tissue VTI1BandCOX7A2P1.a 3233 to 3802 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA068518 cerebellum VTI1BandCOX7A2P1.a 3300 to 3866 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
BM128628 Islets of Langerhans, Pancreas VTI1BandCOX7A2P1.a 3456 to 3967 1 to 512   fully sequenced,   512/512
(100 %)
1 diff
(99.9 %id)
T30577 lung VTI1BandCOX7A2P1.a 3471 to 3827 359 to 1     Submitted on the opposite strand 359/365
(98 %)
8 diff
(97.9 %id)
BF512110   VTI1BandCOX7A2P1.a 3496 to 3840 5 to 349   AAA Submitted on the opposite strand 345/349
(98 %)
6 diff
(98.3 %id)
BG036588 adenocarcinoma, cell line, Prostate VTI1BandCOX7A2P1.a 3590 to 4306 51 to 767       717/770
(93 %)
19 diff
(97.6 %id)
BE181887 head_neck VTI1BandCOX7A2P1.a 3688 to 4024 350 to 14     Submitted on the opposite strand 337/350
(96 %)
0 diff
(100 %id)
DA364848 subthalamic nucleus VTI1BandCOX7A2P1.a 3734 to 4296 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BU183171 melanotic melanoma, skin VTI1BandCOX7A2P1.a 3791 to 4638 1 to 849       849/849
(100 %)
1 diff
(99.9 %id)
BG431341 Kidney VTI1BandCOX7A2P1.a 3853 to 4590 1 to 739       739/740
(99 %)
10 diff
(98.7 %id)
BE870915 adenocarcinoma, colon VTI1BandCOX7A2P1.a 3895 to 4638 1 to 740       740/900
(82 %)
19 diff
(97.9 %id)
FN120726 breast carcinoma VTI1BandCOX7A2P1.a 3908 to 4022 1 to 111       111/111
(100 %)
6 diff
(94.6 %id)
BG163790 hypernephroma, cell line, Kidney VTI1BandCOX7A2P1.a 3931 to 4594 1 to 664       664/955
(69 %)
8 diff
(99.2 %id)
BM128395 Islets of Langerhans, Pancreas VTI1BandCOX7A2P1.a 3937 to 4442 506 to 1   fully sequenced,   506/506
(100 %)
5 diff
(99.1 %id)
CB151074 cervix, Uterine VTI1BandCOX7A2P1.a 3943 to 4532 1 to 590       590/590
(100 %)
0 diff
(100 %id)
BE380051 bladder, carcinoma, cell line VTI1BandCOX7A2P1.a 4055 to 4613 1 to 559   fully sequenced,   559/559
(100 %)
1 diff
(99.9 %id)
CX788559 human embryonic stem cells VTI1BandCOX7A2P1.a 4065 to 4870 1 to 806       806/806
(100 %)
0 diff
(100 %id)
AL135371 melanoma (MeWo cell line) VTI1BandCOX7A2P1.a 4068 to 4817 1 to 750       750/750
(100 %)
0 diff
(100 %id)
AI984330 Kidney VTI1BandCOX7A2P1.a 4072 to 4440 369 to 1       369/369
(100 %)
0 diff
(100 %id)
BM692526 eye, human retina VTI1BandCOX7A2P1.a 4076 to 4641 1 to 566       566/566
(100 %)
0 diff
(100 %id)
FN110500 breast carcinoma VTI1BandCOX7A2P1.a 4102 to 4193 1 to 92       92/92
(100 %)
1 diff
(99.0 %id)
F09641 brain, total brain VTI1BandCOX7A2P1.a 4151 to 4437 287 to 1       287/287
(100 %)
0 diff
(100 %id)
BF573416 melanotic melanoma, high MDR, skin VTI1BandCOX7A2P1.a 4296 to 4930 1 to 636       636/636
(100 %)
3 diff
(99.6 %id)
FN126002 breast carcinoma VTI1BandCOX7A2P1.a 4477 to 4573 99 to 1     Submitted on the opposite strand 99/99
(100 %)
2 diff
(98.0 %id)
BE379627 bladder, carcinoma, cell line VTI1BandCOX7A2P1.a 4583 to 5209 627 to 1   fully sequenced,   627/627
(100 %)
6 diff
(99.1 %id)
FN071052 breast carcinoma VTI1BandCOX7A2P1.a 4616 to 4696 81 to 1     Submitted on the opposite strand 81/82
(98 %)
0 diff
(100 %id)
AI307763 2 pooled tumors (clear cell type), Kidney VTI1BandCOX7A2P1.a 4673 to 5262 594 to 5       590/594
(99 %)
0 diff
(100 %id)
DB333794 Spleen VTI1BandCOX7A2P1.a 4693 to 5259 567 to 1       567/567
(100 %)
0 diff
(100 %id)
DB301974 amygdala VTI1BandCOX7A2P1.a 4713 to 5259 547 to 1       547/547
(100 %)
0 diff
(100 %id)
AA848055 germinal center B cell VTI1BandCOX7A2P1.a 4860 to 5256 419 to 23   AAA   397/397
(100 %)
0 diff
(100 %id)
DB297398 cerebellum VTI1BandCOX7A2P1.a 4875 to 5259 385 to 1       385/385
(100 %)
0 diff
(100 %id)
AA350821 brain VTI1BandCOX7A2P1.a 4893 to 5266 374 to 1       374/374
(100 %)
0 diff
(100 %id)
DB316760 brain VTI1BandCOX7A2P1.a 4893 to 5438 548 to 1       548/553
(99 %)
3 diff
(99.5 %id)
BM929637 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid VTI1BandCOX7A2P1.a 4902 to 5440 1 to 539   tiling clone, fully sequenced, AAA   539/539
(100 %)
0 diff
(100 %id)
AA814663 germinal center B cell VTI1BandCOX7A2P1.a 4906 to 5259 373 to 20   AAA   354/354
(100 %)
0 diff
(100 %id)
AW195664 Kidney VTI1BandCOX7A2P1.a 4910 to 5259 350 to 1       350/350
(100 %)
0 diff
(100 %id)
AI659880 Prostate VTI1BandCOX7A2P1.a 4950 to 5262 319 to 7       313/319
(98 %)
0 diff
(100 %id)
AL135372 melanoma (MeWo cell line) VTI1BandCOX7A2P1.a 4970 to 5256 304 to 18   AAA   287/287
(100 %)
1 diff
(99.7 %id)
BU733030 eye, human retina VTI1BandCOX7A2P1.a 5047 to 5440 412 to 19   AAA   394/394
(100 %)
3 diff
(99.3 %id)
BM683589 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid VTI1BandCOX7A2P1.a 5156 to 5440 301 to 17   fully sequenced, AAA   285/285
(100 %)
0 diff
(100 %id)
AW815109 stomach VTI1BandCOX7A2P1.a 5296 to 5931 11 to 642   tiling clone,   632/728
(86 %)
15 diff
(98.0 %id)
AW815166 stomach VTI1BandCOX7A2P1.a 5296 to 5974 9 to 684   tiling clone,   676/715
(94 %)
9 diff
(98.8 %id)
AW815164 stomach VTI1BandCOX7A2P1.a 5373 to 6007 9 to 642   tiling clone,   634/647
(97 %)
9 diff
(98.7 %id)
BE795826 lung, small cell carcinoma VTI1BandCOX7A2P1.b 1 to 812 46 to 849   tiling clone,   804/895
(89 %)
23 diff
(97.5 %id)
CX167190 human embryonic stem cells differentiated toan early endodermal cell type VTI1BandCOX7A2P1.b 18 to 816 1 to 799       799/799
(100 %)
1 diff
(99.9 %id)
BG421697 Kidney, renal cell adenocarcinoma VTI1BandCOX7A2P1.b 122 to 880 1 to 768       768/1143
(67 %)
27 diff
(97.7 %id)
BF673020 muscle (skeletal) VTI1BandCOX7A2P1.b 191 to 874 1 to 684       684/1010
(67 %)
22 diff
(97.9 %id)
BQ430366 large cell carcinoma, lung VTI1BandCOX7A2P1.b 227 to 874 19 to 672   tiling clone,   654/933
(70 %)
25 diff
(97.4 %id)
BE540343 cervix VTI1BandCOX7A2P1.b 250 to 873 1 to 625       623/844
(73 %)
26 diff
(97.0 %id)
BF125323 melanotic melanoma, skin VTI1BandCOX7A2P1.b 255 to 874 1 to 615       615/902
(68 %)
10 diff
(98.9 %id)
BP356806 mammary gland VTI1BandCOX7A2P1.b 296 to 874 1 to 579       579/589
(98 %)
10 diff
(98.4 %id)
BM714591 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid VTI1BandCOX7A2P1.b 586 to 909 1 to 324   tiling clone, fully sequenced,   324/324
(100 %)
1 diff
(99.7 %id)
BM675355 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid VTI1BandCOX7A2P1.b 848 to 1270 441 to 19   tiling clone, fully sequenced, AAA   423/423
(100 %)
0 diff
(100 %id)
AA594984 Prostate, prostate tumor VTI1BandCOX7A2P1.c 1 to 419 1 to 417   tiling clone, Submitted on the opposite strand 417/417
(100 %)
1 diff
(99.8 %id)
BF436856 Prostate VTI1BandCOX7A2P1.c 394 to 854 461 to 1   tiling clone,   461/461
(100 %)
0 diff
(100 %id)
AI950046 anaplastic oligodendroglioma, brain VTI1BandCOX7A2P1.c 463 to 929 467 to 1   tiling clone,   467/467
(100 %)
0 diff
(100 %id)
BG715307 brain, hypothalamus VTI1BandCOX7A2P1.c 898 to 1664 1 to 772       772/774
(99 %)
32 diff
(95.9 %id)
BI597967 brain, hypothalamus VTI1BandCOX7A2P1.c 898 to 1402 1 to 505       505/505
(100 %)
4 diff
(99.3 %id)
BI603615 brain, hypothalamus VTI1BandCOX7A2P1.c 898 to 1664 1 to 769   tiling clone,   769/769
(100 %)
9 diff
(98.9 %id)
DB467714.
matches multiple genes
hippocampus VTI1BandCOX7A2P1.c 902 to 1317 1 to 417     also hits gene starpoby 417/417
(100 %)
2 diff
(99.6 %id)
DB504231 hypothalamus VTI1BandCOX7A2P1.c 903 to 1387 1 to 485       485/485
(100 %)
1 diff
(99.8 %id)
TI_45214536   VTI1BandCOX7A2P1.c 903 to 1402 97 to 596       500/596
(83 %)
6 diff
(99.0 %id)
TI_45216353   VTI1BandCOX7A2P1.c 903 to 1664 126 to 889       764/889
(85 %)
10 diff
(98.9 %id)
NM_006370.2   VTI1BandCOX7A2P1.c 903 to 2230 1 to 1328   RefSeq, AAA   1328/1328
(100 %)
0 diff
(100 %id)
AW002853 pooled germ cell tumors VTI1BandCOX7A2P1.c 917 to 1388 1 to 474     Submitted on the opposite strand 474/474
(100 %)
16 diff
(96.7 %id)
BG150561 pooled germ cell tumors VTI1BandCOX7A2P1.c 922 to 1413 1 to 492     Submitted on the opposite strand 492/494
(99 %)
5 diff
(99.0 %id)
CB151136 cervix, Uterine VTI1BandCOX7A2P1.c 936 to 1198 1 to 263       263/263
(100 %)
0 diff
(100 %id)
BM909938 astrocytoma grade IV, cell line, brain VTI1BandCOX7A2P1.c 954 to 1762 1 to 814       814/1054
(77 %)
16 diff
(98.5 %id)
AF060902   VTI1BandCOX7A2P1.c 957 to 2230 1 to 1272   AAA   1272/1272
(100 %)
2 diff
(99.9 %id)
BI197025 brain, neuroblastoma VTI1BandCOX7A2P1.c 976 to 1420 1 to 447       447/813
(54 %)
10 diff
(98.8 %id)
BG676708 skin, squamous cell carcinoma VTI1BandCOX7A2P1.c 978 to 1137 1 to 159       159/159
(100 %)
1 diff
(99.4 %id)
BG036426 adenocarcinoma, cell line, Prostate VTI1BandCOX7A2P1.c 980 to 1723 1 to 747       747/752
(99 %)
17 diff
(97.8 %id)
CN341031 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells VTI1BandCOX7A2P1.c 981 to 1417 1 to 438       438/441
(99 %)
6 diff
(98.7 %id)
BE733138 choriocarcinoma, placenta VTI1BandCOX7A2P1.c 998 to 1688 1 to 689       689/689
(100 %)
2 diff
(99.8 %id)
BC003142 Kidney, renal cell adenocarcinoma VTI1BandCOX7A2P1.c 1087 to 2230 1 to 1144   available from MGC, AAA   1144/1144
(100 %)
0 diff
(100 %id)
DA968160 stomach VTI1BandCOX7A2P1.c 1143 to 1668 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DR001271 fetal brain VTI1BandCOX7A2P1.c 1146 to 1951 23 to 828       806/828
(97 %)
7 diff
(99.2 %id)
TI_57221582   VTI1BandCOX7A2P1.c 1152 to 2007 65 to 920 Q170H R171T D172R Q173P L174V ...     856/920
(93 %)
14 diff
(98.5 %id)
BY997323   VTI1BandCOX7A2P1.c 1157 to 1717 19 to 579       561/579
(96 %)
6 diff
(99.0 %id)
BP343210 stomach mucosa VTI1BandCOX7A2P1.c 1158 to 1738 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
CR604112 HeLa cells Cot 25-normalized VTI1BandCOX7A2P1.c 1162 to 2867 1 to 1706   tiling clone,   1706/1706
(100 %)
0 diff
(100 %id)
TI_57199461   VTI1BandCOX7A2P1.c 1162 to 1930 85 to 858       774/858
(90 %)
13 diff
(98.5 %id)
TI_57199619   VTI1BandCOX7A2P1.c 1162 to 1956 58 to 850       793/851
(93 %)
7 diff
(99.2 %id)
BX400880   VTI1BandCOX7A2P1.c 1163 to 2054 1 to 892 E162X V224X     892/892
(100 %)
5 diff
(99.5 %id)
BI113935 muscle, rhabdomyosarcoma VTI1BandCOX7A2P1.c 1163 to 2000 1 to 836 S138K L139P N140E R141P A142G ...     836/841
(99 %)
24 diff
(97.2 %id)
CR603439 Placenta Cot 25-normalized VTI1BandCOX7A2P1.c 1164 to 2191 1 to 1028       1028/1028
(100 %)
0 diff
(100 %id)
CR606212 Placenta Cot 25-normalized VTI1BandCOX7A2P1.c 1164 to 2233 1 to 1070       1070/1070
(100 %)
0 diff
(100 %id)
BM559551 amelanotic melanoma, cell line, skin VTI1BandCOX7A2P1.c 1164 to 2064 1 to 903 V202G T203Q T204P N205T K206S ...     903/1044
(86 %)
20 diff
(98.1 %id)
AK291689 placenta VTI1BandCOX7A2P1.c 1165 to 2610 1 to 1446 K80Q     1446/1446
(100 %)
3 diff
(99.8 %id)
BM562255 amelanotic melanoma, cell line, skin VTI1BandCOX7A2P1.c 1165 to 1960 1 to 805       805/1062
(75 %)
15 diff
(98.6 %id)
AK316572 placenta VTI1BandCOX7A2P1.c 1166 to 1997 1 to 832 I152V     832/832
(100 %)
3 diff
(99.7 %id)
BP360210 thalamus VTI1BandCOX7A2P1.c 1166 to 1748 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BP360263 thalamus VTI1BandCOX7A2P1.c 1166 to 1747 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA621148 Kidney VTI1BandCOX7A2P1.c 1169 to 1726 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BG257199 embryonal carcinoma, cell line, testis VTI1BandCOX7A2P1.c 1171 to 1900 1 to 729       729/739
(98 %)
7 diff
(99.1 %id)
BQ720728 dorsal root ganglia VTI1BandCOX7A2P1.c 1171 to 2014 1 to 845 K178R R200Q K206Q I212Y I213H ...     845/973
(86 %)
16 diff
(98.4 %id)
TI_57162304   VTI1BandCOX7A2P1.c 1172 to 2006 33 to 872 E63D E64G E65G L66A R67T ...     840/872
(96 %)
14 diff
(98.4 %id)
BP196048 adrenal gland VTI1BandCOX7A2P1.c 1175 to 1751 1 to 577       577/581
(99 %)
2 diff
(99.7 %id)
BP196083 adrenal gland VTI1BandCOX7A2P1.c 1175 to 1754 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BP208780 cerebellum VTI1BandCOX7A2P1.c 1175 to 1758 1 to 584       584/584
(100 %)
0 diff
(100 %id)
CN341028 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 VTI1BandCOX7A2P1.c 1175 to 1813 1 to 639       639/639
(100 %)
0 diff
(100 %id)
BE731306 choriocarcinoma, placenta VTI1BandCOX7A2P1.c 1175 to 1935 1 to 759       759/760
(99 %)
9 diff
(98.9 %id)
TI_57148757   VTI1BandCOX7A2P1.c 1175 to 1836 20 to 679       660/679
(97 %)
6 diff
(99.2 %id)
BP215575 corpus callosum VTI1BandCOX7A2P1.c 1178 to 1759 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
BP264279 small intestine VTI1BandCOX7A2P1.c 1178 to 1747 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
DA337430 hippocampus VTI1BandCOX7A2P1.c 1179 to 1759 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BQ267599 insulinoma, Pancreas VTI1BandCOX7A2P1.c 1180 to 1599 9 to 428       420/428
(98 %)
7 diff
(98.4 %id)
TI_57148673   VTI1BandCOX7A2P1.c 1181 to 1896 22 to 735       714/735
(97 %)
6 diff
(99.2 %id)
CA395037 eye, RPE/choroid VTI1BandCOX7A2P1.c 1182 to 1692 1 to 511       511/511
(100 %)
0 diff
(100 %id)
CV570564 cornea, eye VTI1BandCOX7A2P1.c 1182 to 1791 1 to 610       610/610
(100 %)
0 diff
(100 %id)
TI_154152353   VTI1BandCOX7A2P1.c 1187 to 1733 79 to 624       546/547
(99 %)
16 diff
(97.1 %id)
DA337734 hippocampus VTI1BandCOX7A2P1.c 1188 to 1751 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
BI222426 cervical carcinoma cell line, cervix VTI1BandCOX7A2P1.c 1188 to 1830 1 to 642       642/642
(100 %)
1 diff
(99.9 %id)
BE546531 cervical carcinoma cell line, cervix VTI1BandCOX7A2P1.c 1189 to 1900 1 to 703       703/912
(77 %)
12 diff
(98.7 %id)
TI_57152120   VTI1BandCOX7A2P1.c 1189 to 1973 29 to 822       794/1017
(78 %)
27 diff
(97.4 %id)
BG330450 large cell carcinoma, lung VTI1BandCOX7A2P1.c 1190 to 1951 1 to 755       755/940
(80 %)
16 diff
(98.3 %id)
CN341026 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells VTI1BandCOX7A2P1.c 1191 to 1925 1 to 735       735/735
(100 %)
1 diff
(99.9 %id)
CR983530 T-Lymphocytes VTI1BandCOX7A2P1.c 1191 to 1986 1 to 796       796/800
(99 %)
1 diff
(99.9 %id)
BQ286214 Pancreas, Purified pancreatic islet VTI1BandCOX7A2P1.c 1192 to 1667 1 to 476       476/476
(100 %)
3 diff
(99.4 %id)
CB216513 normal endometrium, mid-secretory phase,cycle day 23, uterus VTI1BandCOX7A2P1.c 1192 to 1827 1 to 636       636/636
(100 %)
0 diff
(100 %id)
TI_57150969   VTI1BandCOX7A2P1.c 1192 to 2141 28 to 986 D47H K51N Q52A Q53T E54G ...     959/996
(96 %)
49 diff
(95.1 %id)
TI_154194308   VTI1BandCOX7A2P1.c 1193 to 2065 46 to 912 K190T M198X K201X G222X K227X ...     867/1027
(84 %)
14 diff
(98.7 %id)
CR612585 Neuroblastoma Cot 10-normalized VTI1BandCOX7A2P1.c 1194 to 2178 1 to 985       985/985
(100 %)
0 diff
(100 %id)
BX331276 Neuroblastoma Cot 10-normalized VTI1BandCOX7A2P1.c 1194 to 1793 1 to 599   fully sequenced,   599/599
(100 %)
7 diff
(98.9 %id)
BM476864 leiomyosarcoma, uterus VTI1BandCOX7A2P1.c 1194 to 2002 1 to 821 E162X V202S T203D T204N N205Q ...     821/1171
(70 %)
16 diff
(98.7 %id)
BU077830 insulinoma, Pancreas VTI1BandCOX7A2P1.c 1194 to 1716 21 to 544       524/544
(96 %)
6 diff
(98.9 %id)
CF128433 Chondrosarcoma Lung Metastasis cell lines, lung VTI1BandCOX7A2P1.c 1194 to 1960 1 to 767       767/767
(100 %)
1 diff
(99.9 %id)
TI_57233304   VTI1BandCOX7A2P1.c 1197 to 1934 34 to 777       744/777
(95 %)
12 diff
(98.5 %id)
BG470646 eye, retinoblastoma VTI1BandCOX7A2P1.c 1198 to 2051 1 to 852 V182G N183K T184H S185K E186*     850/852
(99 %)
12 diff
(98.6 %id)
BP295708   VTI1BandCOX7A2P1.c 1199 to 1777 1 to 579       579/579
(100 %)
0 diff
(100 %id)
BI825624 brain, medulla VTI1BandCOX7A2P1.c 1201 to 1353 1 to 153       153/153
(100 %)
0 diff
(100 %id)
TI_44345202   VTI1BandCOX7A2P1.c 1201 to 1575 411 to 786       634/786
(80 %)
13 diff
(98.4 %id)
CN341022 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 VTI1BandCOX7A2P1.c 1202 to 1968 1 to 767       767/767
(100 %)
0 diff
(100 %id)
CN341030 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells VTI1BandCOX7A2P1.c 1204 to 1833 5 to 634       630/634
(99 %)
5 diff
(99.3 %id)
AF035824   VTI1BandCOX7A2P1.c 1229 to 2161 1 to 935 D24N     935/935
(100 %)
11 diff
(98.9 %id)
CN341025 embryonic stem cells, DMSO-treated H9 cellline VTI1BandCOX7A2P1.c 1270 to 2009 1 to 740       740/745
(99 %)
4 diff
(99.5 %id)
BJ996931 hepatoblastoma VTI1BandCOX7A2P1.c 1282 to 1727 1 to 446       446/446
(100 %)
5 diff
(98.9 %id)
BT019348   VTI1BandCOX7A2P1.c 1299 to 1995 1 to 697       697/699
(99 %)
1 diff
(99.9 %id)
BT019960   VTI1BandCOX7A2P1.c 1299 to 1995 1 to 697       697/699
(99 %)
4 diff
(99.5 %id)
CR456757   VTI1BandCOX7A2P1.c 1299 to 1995 1 to 697       697/699
(99 %)
1 diff
(99.9 %id)
CR542095   VTI1BandCOX7A2P1.c 1299 to 1994 1 to 696       696/696
(100 %)
4 diff
(99.5 %id)
TI_1948153086   VTI1BandCOX7A2P1.c 1301 to 2003 124 to 835       721/1403
(51 %)
67 diff
(95.3 %id)
TI_1948153212   VTI1BandCOX7A2P1.c 1301 to 2001 113 to 821   fully sequenced,   718/830
(86 %)
64 diff
(92.3 %id)
TI_1948153490   VTI1BandCOX7A2P1.c 1301 to 1996 119 to 825       716/1466
(48 %)
69 diff
(95.3 %id)
BQ650651 hepatocellular carcinoma, cell line, Liver VTI1BandCOX7A2P1.c 1310 to 2184 13 to 888       876/888
(98 %)
13 diff
(98.6 %id)
TI_227712973   VTI1BandCOX7A2P1.c 1315 to 2230 996 to 92   AAA   905/992
(91 %)
28 diff
(97.2 %id)
TI_1948153360   VTI1BandCOX7A2P1.c 1318 to 2003 802 to 118       685/1113
(61 %)
21 diff
(98.2 %id)
BQ645877 hepatocellular carcinoma, cell line, Liver VTI1BandCOX7A2P1.c 1319 to 2091 1 to 772       772/969
(79 %)
8 diff
(99.2 %id)
BQ648240 hepatocellular carcinoma, cell line, Liver VTI1BandCOX7A2P1.c 1319 to 2237 1 to 932       932/938
(99 %)
22 diff
(97.7 %id)
BQ649038 hepatocellular carcinoma, cell line, Liver VTI1BandCOX7A2P1.c 1319 to 2019 1 to 704       704/939
(74 %)
13 diff
(98.7 %id)
BQ896609 hepatocellular carcinoma, cell line, Liver VTI1BandCOX7A2P1.c 1319 to 2193 1 to 878       878/881
(99 %)
7 diff
(99.3 %id)
BE535613 cervix VTI1BandCOX7A2P1.c 1324 to 2059 1 to 733       733/733
(100 %)
9 diff
(98.8 %id)
BQ065032 lymph, lymphoma, cell line VTI1BandCOX7A2P1.c 1328 to 2231 1 to 907   AAA   907/907
(100 %)
20 diff
(97.8 %id)
BU177307 melanotic melanoma, skin VTI1BandCOX7A2P1.c 1329 to 2207 12 to 900       889/900
(98 %)
32 diff
(96.5 %id)
BM801961 eye, retinoblastoma VTI1BandCOX7A2P1.c 1336 to 2045 1 to 714       714/1180
(60 %)
20 diff
(98.4 %id)
BE384698 melanotic melanoma, skin VTI1BandCOX7A2P1.c 1365 to 1904 1 to 540       540/540
(100 %)
0 diff
(100 %id)
CD656872 Embryonic Stem cells VTI1BandCOX7A2P1.c 1370 to 2179 48 to 853       806/890
(90 %)
12 diff
(98.7 %id)
BI084223 epidermoid carcinoma, cell line, salivary gland VTI1BandCOX7A2P1.c 1387 to 2167 1 to 782   fully sequenced,   782/782
(100 %)
6 diff
(99.3 %id)
CN341023 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 VTI1BandCOX7A2P1.c 1394 to 2061 1 to 668       668/668
(100 %)
0 diff
(100 %id)
BE693951 breast VTI1BandCOX7A2P1.c 1403 to 1664 274 to 12       263/275
(95 %)
0 diff
(100 %id)
BE079631 breast VTI1BandCOX7A2P1.c 1404 to 1985 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BE877027 large cell carcinoma, undifferentiated, lung VTI1BandCOX7A2P1.c 1414 to 2113 1 to 704       704/1065
(66 %)
11 diff
(99.0 %id)
TI_149313286   VTI1BandCOX7A2P1.c 1415 to 2230 894 to 84   AAA   811/982
(82 %)
8 diff
(99.2 %id)
BF090104 nervous_normal VTI1BandCOX7A2P1.c 1420 to 1968 1 to 549       549/549
(100 %)
0 diff
(100 %id)
BY999518   VTI1BandCOX7A2P1.c 1430 to 2009 1 to 580     Submitted on the opposite strand 580/591
(98 %)
1 diff
(99.9 %id)
BG112953 Bone, osteosarcoma, cell line VTI1BandCOX7A2P1.c 1443 to 2195 1 to 752       752/832
(90 %)
8 diff
(99.1 %id)
CF541314 lung VTI1BandCOX7A2P1.c 1455 to 2230 791 to 19   AAA   773/773
(100 %)
4 diff
(99.5 %id)
BM796531 Ascites, stomach VTI1BandCOX7A2P1.c 1458 to 1863 1 to 406       406/406
(100 %)
0 diff
(100 %id)
AI718519 colon VTI1BandCOX7A2P1.c 1472 to 2230 757 to 1       757/773
(97 %)
21 diff
(97.3 %id)
CB161664 Liver VTI1BandCOX7A2P1.c 1477 to 2052 1 to 577       577/577
(100 %)
1 diff
(99.9 %id)
BU625192 cell lines, Enchondroma VTI1BandCOX7A2P1.c 1479 to 2205 745 to 19   AAA   727/727
(100 %)
0 diff
(100 %id)
BE887947 leiomyosarcoma, uterus VTI1BandCOX7A2P1.c 1505 to 2257 1 to 748       748/890
(84 %)
29 diff
(96.8 %id)
AV705986 adrenal gland VTI1BandCOX7A2P1.c 1525 to 2148 1 to 624       624/624
(100 %)
4 diff
(99.4 %id)
BQ575857 Chondrosarcoma Grade II, Left Pelvis VTI1BandCOX7A2P1.c 1536 to 2230 713 to 19   AAA   695/695
(100 %)
1 diff
(99.9 %id)
BF084853 denis_drash VTI1BandCOX7A2P1.c 1540 to 1664 147 to 22       126/147
(85 %)
4 diff
(97.3 %id)
CR610010 Placenta Cot 25-normalized VTI1BandCOX7A2P1.c 1541 to 2233 1 to 693       693/693
(100 %)
0 diff
(100 %id)
AI742734 pooled VTI1BandCOX7A2P1.c 1554 to 2230 690 to 12   AAA   679/682
(99 %)
8 diff
(98.9 %id)
AI766937 2 pooled tumors (clear cell type), Kidney VTI1BandCOX7A2P1.c 1560 to 2237 680 to 2       679/680
(99 %)
11 diff
(98.4 %id)
AW473553 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus VTI1BandCOX7A2P1.c 1572 to 2230 671 to 14   AAA   658/658
(100 %)
3 diff
(99.6 %id)
BQ775842 Bone, Human Chondrosarcoma Cell Line VTI1BandCOX7A2P1.c 1578 to 2230 671 to 19   AAA   653/653
(100 %)
1 diff
(99.9 %id)
CD367332 Alveolar Macrophage, lung VTI1BandCOX7A2P1.c 1598 to 2230 650 to 19   AAA   632/632
(100 %)
2 diff
(99.7 %id)
BF838696 head_neck VTI1BandCOX7A2P1.c 1599 to 2089 508 to 17     Submitted on the opposite strand 492/508
(96 %)
0 diff
(100 %id)
BF838682 head_neck VTI1BandCOX7A2P1.c 1604 to 2093 496 to 7     Submitted on the opposite strand 490/496
(98 %)
1 diff
(99.8 %id)
BQ307402 breast VTI1BandCOX7A2P1.c 1604 to 1701 11 to 109       99/109
(90 %)
8 diff
(92.7 %id)
BQ307521 breast VTI1BandCOX7A2P1.c 1611 to 2063 459 to 8       452/459
(98 %)
1 diff
(99.8 %id)
CA429567 Cell Line, Chondrosarcoma VTI1BandCOX7A2P1.c 1615 to 2230 635 to 19   AAA   617/617
(100 %)
1 diff
(99.9 %id)
BQ049108 lymph, lymphoma, cell line VTI1BandCOX7A2P1.c 1617 to 2448 1 to 835       835/1020
(81 %)
14 diff
(98.7 %id)
BQ049233 lymph, lymphoma, cell line VTI1BandCOX7A2P1.c 1617 to 2617 1 to 1006       1006/1010
(99 %)
16 diff
(98.5 %id)
CB120865 Liver VTI1BandCOX7A2P1.c 1617 to 2123 507 to 1     Submitted on the opposite strand 507/507
(100 %)
1 diff
(99.9 %id)
AA043283 uterus VTI1BandCOX7A2P1.c 1619 to 1869 1 to 251   fully sequenced,   251/251
(100 %)
1 diff
(99.7 %id)
BX099500 uterus VTI1BandCOX7A2P1.c 1621 to 2186 1 to 565       565/565
(100 %)
1 diff
(99.9 %id)
BQ019022 lung, Metastatic Chondrosarcoma VTI1BandCOX7A2P1.c 1626 to 2230 623 to 19   AAA   605/621
(97 %)
0 diff
(100 %id)
TI_154184792   VTI1BandCOX7A2P1.c 1633 to 2170 281 to 817       537/1003
(53 %)
17 diff
(98.4 %id)
BI084715 epidermoid carcinoma, cell line, salivary gland VTI1BandCOX7A2P1.c 1634 to 2185 554 to 3   fully sequenced,   552/554
(99 %)
0 diff
(100 %id)
BE222992 brain, oligodendroglioma VTI1BandCOX7A2P1.c 1641 to 2230 605 to 16   AAA   590/590
(100 %)
0 diff
(100 %id)
BI050331 placenta_normal VTI1BandCOX7A2P1.c 1646 to 1944 316 to 18       299/316
(94 %)
1 diff
(99.7 %id)
TI_57188693   VTI1BandCOX7A2P1.c 1647 to 2239 57 to 650       594/705
(84 %)
7 diff
(99.1 %id)
BQ272174 insulinoma, Pancreas VTI1BandCOX7A2P1.c 1653 to 2236 607 to 24   AAA   584/584
(100 %)
0 diff
(100 %id)
BF998396 placenta_normal VTI1BandCOX7A2P1.c 1679 to 2022 365 to 21       345/365
(94 %)
0 diff
(100 %id)
BF900146 marrow VTI1BandCOX7A2P1.c 1692 to 2030 345 to 1     Submitted on the opposite strand 345/345
(100 %)
2 diff
(99.5 %id)
AW804983 uterus VTI1BandCOX7A2P1.c 1698 to 2057 366 to 7       360/392
(91 %)
0 diff
(100 %id)
AI056325 brain, glioblastoma (pooled) VTI1BandCOX7A2P1.c 1704 to 2230 544 to 18   AAA   527/527
(100 %)
0 diff
(100 %id)
AW167476 serous papillary carcinoma, high grade, 2pooled tumors, uterus VTI1BandCOX7A2P1.c 1707 to 2338 633 to 3       631/633
(99 %)
5 diff
(99.3 %id)
AI337401 colon, colon tumor, RER+ VTI1BandCOX7A2P1.c 1722 to 2233 512 to 1       512/512
(100 %)
0 diff
(100 %id)
AA699826 liver and spleen VTI1BandCOX7A2P1.c 1725 to 2236 512 to 1       512/512
(100 %)
0 diff
(100 %id)
DB236848 trachea VTI1BandCOX7A2P1.c 1761 to 2333 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BX331275 Neuroblastoma Cot 10-normalized VTI1BandCOX7A2P1.c 1763 to 2178 416 to 1   fully sequenced,   416/416
(100 %)
2 diff
(99.6 %id)
AA779908 liver and spleen VTI1BandCOX7A2P1.c 1764 to 2236 485 to 13   AAA   473/473
(100 %)
0 diff
(100 %id)
DB575477 hypothalamus VTI1BandCOX7A2P1.c 1765 to 2230 1 to 466     Submitted on the opposite strand 466/466
(100 %)
1 diff
(99.8 %id)
BU077630 insulinoma, Pancreas VTI1BandCOX7A2P1.c 1771 to 2230 476 to 17   AAA   460/460
(100 %)
0 diff
(100 %id)
BF959105 nervous_normal VTI1BandCOX7A2P1.c 1781 to 2241 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
BQ269578 Pancreas, Purified pancreatic islet VTI1BandCOX7A2P1.c 1782 to 2229 448 to 1       448/448
(100 %)
0 diff
(100 %id)
DB062643 testis VTI1BandCOX7A2P1.c 1783 to 2337 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AV737683 cord Blood VTI1BandCOX7A2P1.c 1794 to 2109 36 to 335       300/335
(89 %)
17 diff
(95.0 %id)
DA288933 hippocampus VTI1BandCOX7A2P1.c 1807 to 2376 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BM461997 leiomyosarcoma, uterus VTI1BandCOX7A2P1.c 1808 to 2707 1 to 904       904/908
(99 %)
15 diff
(98.4 %id)
BE002555 breast_normal VTI1BandCOX7A2P1.c 1814 to 2052 268 to 31     Submitted on the opposite strand 238/268
(88 %)
4 diff
(98.6 %id)
BE002567 breast_normal VTI1BandCOX7A2P1.c 1814 to 2057 261 to 18     Submitted on the opposite strand 244/261
(93 %)
4 diff
(98.5 %id)
BE833759 ovary VTI1BandCOX7A2P1.c 1814 to 2064 262 to 11       252/262
(96 %)
4 diff
(98.5 %id)
AA043333 uterus VTI1BandCOX7A2P1.c 1821 to 2236 419 to 1   fully sequenced,   419/419
(100 %)
3 diff
(99.3 %id)
AA715223 alveolar rhabdomyosarcoma VTI1BandCOX7A2P1.c 1823 to 2231 414 to 1       414/414
(100 %)
11 diff
(97.4 %id)
GW493407 diffuse (Lauren) gastric adenocarcinoma, stomach VTI1BandCOX7A2P1.c 1839 to 2230 122 to 513   AAA   392/513
(76 %)
2 diff
(99.7 %id)
AI205825   VTI1BandCOX7A2P1.c 1851 to 2230 397 to 18   AAA   380/380
(100 %)
0 diff
(100 %id)
BM760562 lymph node, stomach VTI1BandCOX7A2P1.c 1854 to 2165 1 to 312       312/312
(100 %)
0 diff
(100 %id)
BI489836 pooled brain, lung, testis VTI1BandCOX7A2P1.c 1859 to 2230 1 to 372   AAA   372/372
(100 %)
0 diff
(100 %id)
TI_43960449   VTI1BandCOX7A2P1.c 1859 to 2230 62 to 433   AAA   372/433
(85 %)
6 diff
(98.7 %id)
TI_154155855   VTI1BandCOX7A2P1.c 1869 to 2297 89 to 514       426/426
(100 %)
1 diff
(99.8 %id)
TI_1948153213   VTI1BandCOX7A2P1.c 1870 to 2003 254 to 121   fully sequenced,   134/154
(87 %)
0 diff
(100 %id)
BX369656   VTI1BandCOX7A2P1.c 1954 to 2860 1 to 904       904/904
(100 %)
19 diff
(97.9 %id)
CA336388 anterior rhombomeres 1-4 (4 pooled) VTI1BandCOX7A2P1.c 2002 to 2231 29 to 258   AAA   230/258
(89 %)
6 diff
(97.7 %id)
CA336395 anterior rhombomeres 1-4 (4 pooled) VTI1BandCOX7A2P1.c 2012 to 2230 1 to 219   AAA   219/219
(100 %)
0 diff
(100 %id)
CA338236 1st pharyngeal arch (pooled) VTI1BandCOX7A2P1.c 2012 to 2236 1 to 225   AAA   225/225
(100 %)
0 diff
(100 %id)
AI365310 pooled germ cell tumors VTI1BandCOX7A2P1.c 2017 to 2236 220 to 1       220/220
(100 %)
0 diff
(100 %id)
BF954327 nervous_normal VTI1BandCOX7A2P1.c 2117 to 2260 1 to 144       144/144
(100 %)
0 diff
(100 %id)
BM472482 melanotic melanoma, skin VTI1BandCOX7A2P1.c 2134 to 2848 39 to 765       727/1100
(66 %)
14 diff
(98.8 %id)
DB229559 trachea VTI1BandCOX7A2P1.c 2190 to 2783 2 to 595   capped   594/594
(100 %)
1 diff
(99.9 %id)
DB144163 thymus VTI1BandCOX7A2P1.c 2197 to 2749 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
TI_154153111   VTI1BandCOX7A2P1.c 2365 to 2578 80 to 293       214/249
(85 %)
1 diff
(99.6 %id)
BJ996932 hepatoblastoma VTI1BandCOX7A2P1.c 2420 to 2882 463 to 1   tiling clone,   463/463
(100 %)
0 diff
(100 %id)
DA356376 subthalamic nucleus VTI1BandCOX7A2P1.d 1 to 573 2 to 574   tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
AI831286 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) VTI1BandCOX7A2P1.d 403 to 967 566 to 1   tiling clone,   566/568
(99 %)
1 diff
(99.9 %id)
AK310839 trachea VTI1BandCOX7A2P1.e 1 to 1102 2 to 1103 exact tiling clone,   1103/1103
(100 %)
1 diff
(100.0 %id)
DB215119 trachea VTI1BandCOX7A2P1.e 1 to 459 2 to 460   capped   459/459
(100 %)
1 diff
(99.8 %id)
TI_57170685   VTI1BandCOX7A2P1.e 22 to 692 69 to 739   tiling clone,   671/739
(90 %)
7 diff
(99.1 %id)
H84263 eye, retina VTI1BandCOX7A2P1.e 317 to 554 1 to 235       235/235
(100 %)
4 diff
(98.3 %id)
AI915807 Kidney VTI1BandCOX7A2P1.f 1 to 341 341 to 1 exact tiling clone,   341/341
(100 %)
0 diff
(100 %id)
GD136676   VTI1BandCOX7A2P1.f 128 to 340 1 to 213   AAA   213/213
(100 %)
2 diff
(99.1 %id)
AI361738 B-cell, chronic lymphotic leukemia VTI1BandCOX7A2P1.g-u 1 to 421 443 to 23   tiling clone,   421/443
(95 %)
0 diff
(100 %id)
BG537904 lung VTI1BandCOX7A2P1.g-u 385 to 945 1 to 573 P45T H46T Q47R A48L N49I ... tiling clone,   573/726
(78 %)
26 diff
(96.5 %id)
BU198602   Gene VTI1BandCOX7A2P1, variant not shown         Suspected internal deletion, this clone was ignored    
F07146 brain, total brain Gene VTI1BandCOX7A2P1, variant not shown              
Z40252 brain, total brain Gene VTI1BandCOX7A2P1, variant not shown              
F04621 brain, total brain Gene VTI1BandCOX7A2P1, variant not shown              
F08404 brain, total brain Gene VTI1BandCOX7A2P1, variant not shown              
BF680457 Prostate Gene VTI1BandCOX7A2P1, variant not shown         Suspected internal deletion, this clone was ignored    
TI_159718376   Gene VTI1BandCOX7A2P1, variant not shown              
CB852658 Human Lung Epithelial cells, lung Gene VTI1BandCOX7A2P1, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI